ADMA vs REGN: Which Stock is Better?

Side-by-side comparison of Adma Biologics Inc and Regeneron Pharmaceuticals Inc in 2026

Comparison Updated:

ADMA

Adma Biologics Inc

$17.59

REGN

Regeneron Pharmaceuticals Inc

$733.78

Key Metrics Comparison

MetricADMAREGNWinner
Market Cap$4.20B$77.77BREGN
P/E Ratio20.4517.58REGN
EPS (TTM)$0.86$41.75REGN
Revenue Growth0.1%0.0%ADMA
Gross Margin54.7%45.8%ADMA

Analyze ADMA

Full quant analysis

Analyze REGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is ADMA or REGN a better investment?

Comparing ADMA and REGN: Adma Biologics Inc has a market cap of $4.20B while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between ADMA and REGN?

ADMA (Adma Biologics Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: ADMA or REGN?

Based on P/E ratios, REGN trades at a lower multiple (17.6x vs 20.5x).

Which is growing faster: ADMA or REGN?

ADMA has higher revenue growth at 0.1% vs 0.0% for REGN.

Which company is more profitable: ADMA or REGN?

Adma Biologics Inc (ADMA) has higher gross margins at 54.7% compared to 45.8% for REGN.

Which is the larger company: ADMA or REGN?

Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $4.20B for ADMA.

Should I buy ADMA or REGN in 2026?

Both ADMA and REGN have investment merit. ADMA trades at $17.59 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between ADMA and REGN stock?

Key differences: Market Cap ($4.20B vs $77.77B), P/E Ratio (20.5x vs 17.6x), Revenue Growth (0.1% vs 0.0%), Gross Margin (54.7% vs 45.8%).

Popular Stock Comparisons